1Leeuwenburgh Ⅰ,Stijnen PJ,Verburg GP.Recovery of chronic hepatitis by treatment of concomitant hypesthyroidism.Eur J Gastroenterol Hepatol,2001,13:1389.
2Aydemir S,Bayraktaroglu T,Demircan N,et al.Effect of hyperthyroidism and propylthiouracil treatment on liver biochemical tests.Int J Clin Pract,2005,59:1304.
3Majeed M,Babu A.Cholestasis secondary to hyperthyroidism made worse by methimazole,Am J Med Sci,2006,332:51.
4Malik R,Hodgson H.The relationship between the thyroid gland and the liver.Quarterly Journal of Medicine,2002,95:559.
5Mikhail NE.Methimazole induced choleatatic jaundice.South Med J,2004,97:178.
2Videla L A, Smok G, Troncoso P, et al. Influence of hyperthyroidism on lindaneinducedhepatotoxicity in the vat [J]. Biochem Pharmacol, 1995, 50(10). 557.
3Woeber K A. Thyrotoxicosis and cardiac disease [J]. Heart Dis Surobe, 1993,2(5) :415.
4Liaw YF, Huang MJ, Fan KD, et al. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intern Med,1993,118:424-428.
5Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol,1990,11:272-276.
6Williams KV, Nayak S, Becker D, et al. Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? J Clin Endocrinol Metab,1997,82:1727-1733.
7Cooper DS. Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD. eds. Werner and Ingbar′s the thyroid. 7th ed. Philadelphia: Lippincott-Raven, 1996.713-734.
8Huang MJ, Li KL, Wei JS, et al. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study. Am J Gastroenterol, 1994, 89:1071-1076.
9Kim HJ, Kim BH, Han YS, et al. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study. Am J Gastroenterol, 2001,96:165-169.
10Garty BZ, Kauli R, Ben-Ari J, et al. Hepatitis associated with propylthiouracil treatment. Drug Intell Clin Pharm, 1985,19:740-742.
